Autolus Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $29 | $0 | $0 | $10,091 |
Gross Profit | 29 | -223 | -1,895 | 8,285 |
EBITDA | -54,902 | -69,448 | -46,152 | -31,623 |
EBIT | -56,979 | -71,386 | -48,047 | -33,429 |
Net Income | -27,606 | -82,094 | -58,272 | -52,690 |
Net Change In Cash | 29 | 0 | 0 | 10,091 |
Free Cash Flow | -61,790 | -86,329 | -51,924 | -41,046 |
Cash | 227,380 | 657,067 | 705,939 | 759,544 |
Basic Shares | 255,161 | 266,084 | 266,025 | 222,170 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $10,120 | $1,698 | $6,194 | $2,330 |
Gross Profit | -1,267 | -4,867 | -131,026 | -126,321 |
EBITDA | -202,124 | -156,770 | -135,536 | -132,006 |
EBIT | -209,840 | -163,335 | -142,958 | -140,554 |
Net Income | -220,662 | -208,383 | -148,839 | -142,096 |
Net Change In Cash | 10,120 | 1,698 | 6,194 | 2,330 |
Free Cash Flow | -206,271 | -156,573 | -123,149 | -126,718 |
Cash | 227,380 | 239,566 | 382,436 | 310,338 |
Basic Shares | 255,161 | 173,941 | 94,993 | 72,084 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.09 |
2024-09-30 | -$0.31 |
2024-06-30 | -$0.22 |
2024-03-31 | -$0.24 |
